DossierENTITY

deramiocel

Coverage of deramiocel in the Nexus archive.

Earliest in view: May 8 · 13:37 UTCMost recent: May 8 · 13:37 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 8 · 13:37 UTCSTAT NEWS
STAT+: The biotech news you need to read today
Capricor Therapeutics is suing its partner Nippon Shinyaku over the launch of its Duchenne therapy, claiming they botched preparations and created an inaccessible pricing structure. The biotech company is fighting for its promising treatment, deramiocel. This lawsuit may impact the accessibility of the treatment for patients.